UCSF Research at ZSFG during COVID-19

ZSFG Employee Screening Form


Selected Announcements and Guidance from DPH and the UCSF Office of Research

A full list of communications from the Office of Research regarding Coronavirus (COVID-19) Related Guidance to Researchers can be found at https://research.ucsf.edu/.

January 6, 2021 - Effective January 14th, staff screening is transitioning to online screening only.

December 31, 2020 - ZSFG Return to Work Guidance has been updated:

  • Employees who return from international travel are mandated to quarantine for 10 days with testing offered between day 5-9 from date of return.
  • Emloyees who return from domestic travel outside of the Bay area may continue to work if asymptomatic but are strongly recommended to quarantine for 10 days. Testing may be offered to those with significant risk of domestic travel-related exposure.
  • Although there is no explicit statement on HR/leave guidance in the linked document, OHS will counsel employees to contact managers/supervisors regarding travel-related leave. We understand it that travel-related time off will not be considered covid leave, but personal/vacation time.

December 29, 2020 - The Chancellor’s Executive Team (CET) has approved an extension of the current decreased research density levels until 12:01 a.m. on January 19, at which point it will be reassessed and may be extended.

As announced on December 18, the current densities (effective December 24, 2020, and now extended until January 19, 2021) are:

  1. Laboratory research density at 25%. LARC operations will continue unabated, and there is no need to reduce animal census.
  2. Clinical research that is not essential to the health of the participant (termed Category 3 research) at 12.5%. It is strongly recommended that research-only onsite visits (i.e., conducted without a concomitant clinical visit) be postponed. COVID-19 clinical research and clinical research determined to be essential to the health and/or well-being of the participant can continue without density restriction.

December 9, 2020 - ZSFG Return to Work Guidance has been updated:

  • Quarantine period after community household exposure and high-risk work exposure is shortened to 10 days (previously 14 days), with testing offered at 7-9 days after exposure (previously 5-7 days)
  • After return from international travel, self-quarantine is recommended but not required. (If employees make the decision to travel, the time used to self-quarantine does not qualify for COVID leave- per HR).

Please note that gatherings outside of the county or state are not exempt from guidance. Any gathering regardless of location is not currently recommended.
Individuals returning from travel involving gatherings do not need to self quarantine unless they are symptomatic, or have known exposure to someone who is positive or suspected to have COVID-19.

November 2, 2020 - The UCSF Office of Research is strongly encouraging all Clinical Research Coordinators to complete a new online training course, Clinical Research During COVID-19, before the end of November. The brief course is hosted on the UC Learning platform and takes approximately 15 minutes to complete. Additional details including instructions for how to access the course are posted on the Office of Research website.

October 7, 2020 - ZSFG Return to Work Guidance has been updated to clarify:

  • circumstances in which employees with household members that have unconfirmed yet high likelihood for having COVID-19 may be quarantined out of work by ZSFG OHS (footnote at the end of Table 4).
  • ZSFG and UCSF have slight differences in return to work guidelines. At ZSFG, employees with high risk exposures will be quarantined for 14 days. In other exposure cases, as long as an individual is asymptomatic, they may continue to work. This difference is allowed under CDC staffing shortage mitigation plan.
    UCSF employees working at ZSFG will only need to follow ZSFG guidance, but when working at another UCSF location they will need to follow UCSF guidance requiring 14-day quarantine and symptom monitoring for both high and medium risk exposures.
  • ZSFG OHS will cc [email protected] representatives with communications on return to work letters. These letters do not contain specific health information, and primarily serve to notify HR departments on expected off work/return to work dates.

September 15, 2020 - Phase 3 of increased onsite research will begin on September 17. Laboratory-based research allowable density will increase to 50% density, or the equivalent of one person per two workstations, and the allowable density for onsite Category 3 clinical research will increase to 25%.

June 26, 2020 - Updated guidance for clinical research, including a Return to Work Checklist with useful information and links for general considerations and research participants.

June 4, 2020 - Phase 2 of the laboratory-based research reopening will begin on June 8th, in which the allowable density will increase to 25% capacity, or about one person per four workstations.

May 14, 2020 - Guidance for Phase 1 of the Planning for Gradual Increase of UCSF Research Activity.


ZSFG-Specific FAQ for the Gradual Increase of UCSF Research Activity

This FAQ addresses aspects of this initiative that are unique and specific to ZSFG and is not intended to reiterate information provided in the UCSF guidance. It represents the best current knowledge and will be continually updated as new information becomes available.

If you have questions about the ZSFG-specific policy, please email [email protected].
For questions about the UCSF policy, please email [email protected].



Access & Security


Clinical Research

Wet Lab Research

Additional Information